Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Front Psychol ; 13: 866551, 2022.
Article in English | MEDLINE | ID: mdl-35602707

ABSTRACT

Sexual and reproductive health is a challenge worldwide, and much progress is needed to reach the relevant UN Sustainable Development Goals. This paper presents cross-sectional data collected in Sierra Leone on sexual and gender-based violence (SGBV), family planning (FP), child, early and forced marriage (CEFM), and female genital mutilation (FGM) using an innovative method of measurement: situational judgment tests (SJTs), as a subset of questions within a larger survey tool. For the SJTs, respondents saw hypothetical scenarios on these themes and had to indicate how they would react. The objective is to give an impression of beliefs and norms on specific behaviors, which provide insights for social and behavior change interventions. Data was collected by enumerators traveling to villages randomly selected in six districts of the country. The sample is composed of 566 respondents. Results show that FGM in particular seem to be a priority topic, in comparison to the other topics for which the norms seem to be stronger against those practices. Age differences emerged and suggest priority groups to be targeted (e.g., on the topic of female genital mutilation, younger female respondents, and older male respondents gave the lowest coded responses which reflected to less appropriate behavior in our coding). In terms of validity of the measurement methods, situational judgment test answers correlated positively with other items in the survey, but the magnitude of the association is often small, and sometimes not significant. Thus, more studies are needed to further explore the validity of this measure by comparing against a reference value. Using SJTs could complement other data collection tools to perform community assessment, and orient the direction of the program in its planning phase.

2.
Contact Dermatitis ; 81(3): 161-166, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31206704

ABSTRACT

BACKGROUND: Allergic contact dermatitis caused by glucose sensors has become an increasing problem. Contact allergies to isobornyl acrylate, colophonium, ethyl cyanoacrylate and N,N-dimethylacrylamide have been reported. However, there is a paucity of information regarding the prevalence of sensor-related dermatitis and detailed patient histories. OBJECTIVES: To evaluate diabetes patients who have developed allergic contact dermatitis caused by glucose sensors. PATIENTS AND METHODS: Seventy patients with suspected contact allergy to glucose sensors referred to university hospital dermatology clinics in southern Finland were patch tested with the baseline series, an isobornyl acrylate dilution series, and a number of other acrylates. Atopic constitution, contact allergies, the severity of the dermatitis and the ability to continue with the same or another type of sensor were recorded. RESULTS: Positive patch test reactions to isobornyl acrylate were seen in 51 of 63 (81%) Freestyle Libre users. Colophonium or its derivatives gave positive reactions in five of seven Medtronic Enlite users. The median duration of sensor use before dermatitis was 6 months. The estimated prevalences of contact allergy to sensor adhesives were 0.7% for Freestyle Libre and 0.8% for Enlite. CONCLUSIONS: We suggest that patients who have difficulties in finding a tolerable glucose sensor or an insulin pump should be patch tested.


Subject(s)
Acrylates/adverse effects , Blood Glucose Self-Monitoring/instrumentation , Camphanes/adverse effects , Dermatitis, Allergic Contact/etiology , Disposable Equipment , Resins, Plant/adverse effects , Adolescent , Adult , Aged , Child , Child, Preschool , Dermatitis, Allergic Contact/prevention & control , Diabetes Mellitus, Type 1/blood , Female , Humans , Male , Middle Aged , Patch Tests , Young Adult
3.
Contact Dermatitis ; 77(3): 159-162, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28421670

ABSTRACT

BACKGROUND: In 2016, dermatologists in Finland suspected contact allergy in several patients using moisturizers under the trade name Apobase®. Following a formulation change, Phenostat™, which is a mixture of phenoxyethanol, caprylhydroxamic acid, and methylpropanediol, was used as a preservative in Apobase® moisturizers in Finland. OBJECTIVES: To confirm the suspected contact allergy to Apobase® cream, oily cream, and/or lotion, and to identify the specific contact allergen and define its optimal patch test concentration. METHODS: Thirty-nine patients with suspected contact allergy to Apobase® creams or lotion were patch tested in four Finnish dermatological clinics. The patch tests included old and new Apobase® formulas and their preservative agents: phenoxyethanol, methylpropanediol, and dilution series of Phenostat™ and caprylhydroxamic acid or its potassium salt. RESULTS: The patch tests showed positive reactions to the new Apobase® formulas, Phenostat™, and caprylhydroxamic acid or its potassium salt, but not to the old Apobase® formulas, methylpropanediol, or phenoxyethanol. CONCLUSIONS: We found a new contact allergen, caprylhydroxyamic acid, which caused an epidemic of allergic contact dermatitis in patients using moisturizers containing this preservative. Whether the sensitizing capacity of caprylhydroxamic acid depends on the other chemicals used in Apobase® moisturizers needs further investigation.


Subject(s)
Allergens/adverse effects , Caprylates/adverse effects , Dermatitis, Allergic Contact/etiology , Adult , Female , Finland , Hand Dermatoses/complications , Humans , Male , Middle Aged , Patch Tests/adverse effects , Preservatives, Pharmaceutical
4.
Acta Derm Venereol ; 97(4): 456-463, 2017 Apr 06.
Article in English | MEDLINE | ID: mdl-27840886

ABSTRACT

The contribution of filaggrin null mutations to predicting atopic dermatitis (AD) treatment response is not clear, nor have such mutations been studied in the Finnish population. This study tested the association of the 4 most prevalent European FLG null mutations, the 2 Finnish enriched FLG null mutations, the FLG 12-repeat allele, and 50 additional epidermal barrier gene variants, with risk of AD, disease severity, clinical features, risk of other atopic diseases, age of onset, and treatment response in 501 patients with AD and 1,710 controls. AD, early-onset AD, palmar hyperlinearity, and asthma showed significant associations with the combined FLG null genotype. Disease severity and treatment response were independent of patient FLG status. Carrier frequencies of R501X, 2282del4, and S3247X were notably lower in Finns compared with reported frequencies in other populations. This data confirms FLG mutations as risk factors for AD in Finns, but also questions their feasibility as biomarkers in predicting treatment response.


Subject(s)
Dermatitis, Atopic/drug therapy , Dermatitis, Atopic/genetics , Immunosuppressive Agents/therapeutic use , Intermediate Filament Proteins/genetics , Mutation , Pharmacogenomic Variants , Adolescent , Adult , Case-Control Studies , Dermatitis, Atopic/diagnosis , Female , Filaggrin Proteins , Finland , Gene Frequency , Genetic Predisposition to Disease , Heterozygote , Homozygote , Humans , Male , Middle Aged , Pharmacogenetics , Phenotype , Prospective Studies , Severity of Illness Index , Treatment Outcome , Young Adult
5.
J Agric Food Chem ; 63(9): 2525-36, 2015 Mar 11.
Article in English | MEDLINE | ID: mdl-25664918

ABSTRACT

Two bottles of beer from an about 170-year-old shipwreck (M1 Fö 403.3) near the Åland Islands in the Baltic Sea were analyzed. Hop components and their degradation compounds showed that the bottles contained two different beers, one more strongly hopped than the other. The hops used contained higher levels of ß-acids than modern varieties and were added before the worts were boiled, converting α-acids to iso-α-acids and ß-acids to hulupones. High levels of organic acids, carbonyl compounds, and glucose indicated extensive bacterial and enzyme activity during aging. However, concentrations of yeast-derived flavor compounds were similar to those of modern beers, except that 3-methylbutyl acetate was unusually low in both beers and 2-phenylethanol and possibly 2-phenylethyl acetate were unusually high in one beer. Concentrations of phenolic compounds were similar to those in modern lagers and ales.


Subject(s)
Acids/analysis , Beer/analysis , Acids/metabolism , Beer/history , Beer/microbiology , Carbohydrate Metabolism , Carbohydrates/analysis , Fermentation , History, 17th Century , Odorants/analysis , Ships/history , Yeasts/isolation & purification , Yeasts/metabolism
6.
Ann Allergy Asthma Immunol ; 112(1): 46-52, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24331393

ABSTRACT

BACKGROUND: Oxidative hair dyes commonly contain paraphenylene diamine (PPD) and its derivatives, a well-known cause of delayed hypersensitivity among both consumers and hairdressers. They are also considered possible causes of occupational respiratory diseases. Despite the widespread use of hair dyes, there are only a few reports of asthma, rhinitis, and contact urticaria caused by PPD and related compounds. OBJECTIVE: To characterize patients with occupational asthma, rhinitis, or contact urticaria associated with oxidative hair dyes and to evaluate the diagnostic methods. METHODS: We reviewed the patient files of the Finnish Institute of Occupational Health for the period January 1, 2001, through May 31, 2011, to identify patients diagnosed as having asthma, rhinitis, or contact urticaria associated with oxidative hair dyes. The diagnoses of asthma and rhinitis were based on specific inhalation challenges with hair dye products. Skin prick tests were performed with hair dye ingredients as hapten conjugates of human serum albumin and with hair dye products and ingredients as is. Open skin tests confirmed the diagnosis of contact urticaria. RESULTS: We describe 11 hairdressers with occupational asthma (5 cases), rhinitis (5 cases), and contact urticaria (3 cases) due to hair dyes. Of the 52 specific inhalation challenges performed, 9 (17%) had positive results. One patient who experienced an anaphylactic reaction when having her own hair dyed had positive skin prick test results to PPD and toluene-2,5-diamine sulfate. CONCLUSION: Hairdressers are at risk for occupational asthma, rhinitis, and contact urticaria due to oxidative hair dyes. Skin prick testing may be insensitive for detecting immediate hypersensitivity to PPD and related compounds.


Subject(s)
Asthma, Occupational/chemically induced , Hair Dyes/adverse effects , Phenylenediamines/adverse effects , Rhinitis/chemically induced , Urticaria/chemically induced , Adult , Anaphylaxis/chemically induced , Female , Humans , Male , Middle Aged , Occupational Exposure , Patch Tests , Phenylenediamines/immunology , Respiratory Function Tests , Young Adult
8.
J Dermatolog Treat ; 21(3): 167-70, 2010 May.
Article in English | MEDLINE | ID: mdl-20394492

ABSTRACT

OBJECTIVES: To examine the 10-year outcome of affected body surface area (BSA), respiratory symptoms, and serum IgE in adult AD patients 6 years after a 4-year intervention with topical tacrolimus. METHODS: Patients who 10 years ago participated in a 4-year, open tacrolimus study (n = 65) were contacted for assessment of affected BSA, bronchial hyper-reactivity (BHR), respiratory symptoms, skin prick tests and serum IgE. RESULTS: Altogether, 50 (77%) patients attended the follow-up visit. The median affected BSA decreased from 19% to 1.6% during the 10-year follow-up (p < 0.0001). Patients with active asthma and rhinitis symptoms at baseline reported a significant decrease at the follow-up (p = 0.02 andp = 0.01). In patients with BHR at baseline, the provocative dose of inhaled histamine producing a 15% decrease in FEV(1) increased. Responders (>or= 60% improvement of affected BSA) to tacrolimus treatment at the 1-year visit had a significantly smaller affected BSA at the 4- and 10-year visits than non-responders (< 60% improvement). Responders also showed a significant decrease in serum IgE at the follow-up visit compared to baseline (p = 0.002). CONCLUSIONS: The long-term, effective treatment of patients with AD may have a beneficial effect on affected BSA, respiratory symptoms, and serum IgE.


Subject(s)
Bronchial Hyperreactivity/physiopathology , Dermatitis, Atopic/drug therapy , Eczema/physiopathology , Immunoglobulin E/analysis , Tacrolimus/therapeutic use , Administration, Topical , Adolescent , Adult , Asthma/complications , Asthma/physiopathology , Body Surface Area , Bronchial Hyperreactivity/complications , Cohort Studies , Dermatitis, Atopic/complications , Dermatitis, Atopic/immunology , Dose-Response Relationship, Drug , Drug Administration Schedule , Eczema/complications , Female , Follow-Up Studies , Humans , Male , Middle Aged , Respiratory Function Tests , Retrospective Studies , Risk Assessment , Skin Tests , Tacrolimus/adverse effects , Time Factors , Young Adult
9.
Acta Derm Venereol ; 90(2): 170-4, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20169301

ABSTRACT

A one-year, randomized, double-blind study was conducted in 80 patients with atopic dermatitis treated with tacrolimus ointment or a corticosteroid regimen (hydrocortisone acetate 1% ointment for head and neck, hydrocortisone butyrate 0.1% ointment for trunk and limbs) to compare efficacy and safety, and effects on Th2-reactivity. The study was completed by 36/40 patients in the tacrolimus group, and 31/40 patients in the corticosteroid group. In both groups affected body surface area, eczema area and severity index, and transepidermal water loss decreased at months 6 and 12. Tacrolimus was superior for all efficacy scores at month 6, and in the head and neck area at month 12. Recall antigen reactivity increased at month 12 in both groups. Adverse events were reported by 40/40 patients in the tacrolimus, and by 34/40 patients in the corticosteroid group. Long-term treatment with topical tacrolimus or a corticosteroid regimen improves atopic dermatitis and recall antigen reactivity, suggesting an improvement in the Th1/Th2-balance.


Subject(s)
Adrenal Cortex Hormones/administration & dosage , Anti-Inflammatory Agents/administration & dosage , Butyrates/administration & dosage , Dermatitis, Atopic/drug therapy , Hydrocortisone/analogs & derivatives , Immunosuppressive Agents/administration & dosage , Tacrolimus/administration & dosage , Administration, Topical , Adrenal Cortex Hormones/adverse effects , Adult , Anti-Inflammatory Agents/adverse effects , Butyrates/adverse effects , Dermatitis, Atopic/immunology , Dermatitis, Atopic/pathology , Double-Blind Method , Female , Finland , Humans , Hydrocortisone/administration & dosage , Hydrocortisone/adverse effects , Immunoglobulin E/blood , Immunosuppressive Agents/adverse effects , Male , Ointments , Tacrolimus/adverse effects , Time Factors , Treatment Outcome , Water Loss, Insensible/drug effects , Young Adult
10.
Appl Environ Microbiol ; 75(8): 2333-45, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19181838

ABSTRACT

The use of more concentrated, so-called high-gravity and very-high-gravity (VHG) brewer's worts for the manufacture of beer has economic and environmental advantages. However, many current strains of brewer's yeasts ferment VHG worts slowly and incompletely, leaving undesirably large amounts of maltose and especially maltotriose in the final beers. alpha-Glucosides are transported into Saccharomyces yeasts by several transporters, including Agt1, which is a good carrier of both maltose and maltotriose. The AGT1 genes of brewer's ale yeast strains encode functional transporters, but the AGT1 genes of the lager strains studied contain a premature stop codon and do not encode functional transporters. In the present work, one or more copies of the AGT1 gene of a lager strain were repaired with DNA sequence from an ale strain and put under the control of a constitutive promoter. Compared to the untransformed strain, the transformants with repaired AGT1 had higher maltose transport activity, especially after growth on glucose (which represses endogenous alpha-glucoside transporter genes) and higher ratios of maltotriose transport activity to maltose transport activity. They fermented VHG (24 degrees Plato) wort faster and more completely, producing beers containing more ethanol and less residual maltose and maltotriose. The growth and sedimentation behaviors of the transformants were similar to those of the untransformed strain, as were the profiles of yeast-derived volatile aroma compounds in the beers.


Subject(s)
Maltose/metabolism , Membrane Transport Proteins/genetics , Membrane Transport Proteins/metabolism , Saccharomyces/enzymology , Saccharomyces/metabolism , Trisaccharides/metabolism , Beer/microbiology , DNA, Fungal/chemistry , DNA, Fungal/genetics , Ethanol/metabolism , Fermentation , Genes , Molecular Sequence Data , Monosaccharide Transport Proteins/genetics , Monosaccharide Transport Proteins/metabolism , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Recombination, Genetic , Saccharomyces/genetics , Saccharomyces cerevisiae Proteins/genetics , Saccharomyces cerevisiae Proteins/metabolism , Sequence Analysis, DNA , Symporters/genetics , Symporters/metabolism , Transformation, Genetic
13.
Acta Ophthalmol Scand ; 84(5): 693-5, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16965503

ABSTRACT

PURPOSE: To evaluate the efficacy and effect of tacrolimus ointment on conjunctival cytology in patients with atopic blepharoconjunctivitis or keratoconjunctivitis. METHODS: Ten patients with severe atopic blepharoconjunctivitis treated with 0.03% tacrolimus ointment once daily as an intermittent treatment were analysed retrospectively. The main outcome measures were clinical response to topical tacrolimus, adverse events and changes in the inflammatory cells obtained from conjunctival brush samples. RESULTS: Marked clinical responses in blepharitis and conjunctivitis symptoms were seen after a mean follow-up time of 6 weeks. Clinical scores decreased by 67% in blepharitis and 74% in conjunctivitis symptoms. No severe adverse events or signs of immunosuppression such as herpes simplex infections occurred. No significant changes occurred in visual acuity, refraction, anterior chamber, retina or intraocular pressure. Median decreases were 85% (p =0.01) in conjunctival eosinophils, 50% (p = 0.01) in neutrophils and 58% (p = 0.02) in lymphocytes. CONCLUSIONS: Tacrolimus ointment is potentially a safe and effective treatment for atopic blepharoconjunctivitis. Regular treatment of the eyelids once daily may also lead to clinical and cytological improvement of the conjunctivitis.


Subject(s)
Blepharitis/drug therapy , Conjunctiva/drug effects , Conjunctiva/pathology , Conjunctivitis, Allergic/drug therapy , Immunosuppressive Agents/administration & dosage , Tacrolimus/administration & dosage , Adult , Blepharitis/pathology , Conjunctivitis, Allergic/pathology , Female , Humans , Immunosuppressive Agents/adverse effects , Male , Ointments , Retrospective Studies , Tacrolimus/adverse effects , Treatment Outcome
14.
Eur J Nutr ; 45(1): 45-51, 2006 Feb.
Article in English | MEDLINE | ID: mdl-15864408

ABSTRACT

BACKGROUND: In vitro fermentation models have been used widely for studies of shortchain fatty acid (SCFA) formation from carbohydrates, whereas the suitability of these methods for enterolactone (ENL) formation has received less attention. AIM: The aim was to study the suitability of an in vitro fermentation model for prediction of bioconversion of lignans to ENL, to compare the approach with that of an in vivo rat model and to study the SCFA formation in both models. METHODS: Predigested samples of rye bran (R), flaxseed meal (F) alone, or in combination with rye bran (R&F) and a faecal control were incubated in an in vitro fermentation model using human faecal microbiota. In the in vivo experiment rats consumed a non-fibre control diet (C) or diets supplemented either with rye bran (R), flaxseed meal (F) alone, or with their combination (R&F) for four weeks. Enterodiol (END), ENL and SCFA concentrations were measured from in vitro faecal fermentation samples and from the intestinal contents of rats. Plasma ENL concentrations from rats were also measured. RESULTS: The highest ENL production was found in vitro with the F supplement (areas under curve: 740 +/- 4, 7,500 +/- 400, 2,600 +/- 500 and 1,520 +/- 70 nmol x h for the R, F, R&F supplements and faecal control, respectively). In vivo, the concentration of ENL in caecal digesta from flaxseed meal was significantly (P < 0.05) enhanced by the presence of rye bran (medians 261, 407 and 24 nmol/g in the F, R&F and C groups, respectively). No correlation was found between the models regarding ENL production, possibly due to different responses to the presence of rye bran matrix, differences in microbiota or application of a batch in the in vitro fermentation model. Rye bran supplementation enhanced butyrate production both in vitro and in vivo. CONCLUSION: In vitro fermentation and the in vivo rat models responded differently to the presence of rye bran and no correlation with regard to the ENL formation from flaxseed lignans was observed.


Subject(s)
4-Butyrolactone/analogs & derivatives , Dietary Fiber/metabolism , Feces/microbiology , Flax , Lignans/metabolism , 4-Butyrolactone/analysis , 4-Butyrolactone/metabolism , 4-Butyrolactone/pharmacokinetics , Animals , Area Under Curve , Dietary Fiber/pharmacology , Fatty Acids, Volatile/analysis , Fatty Acids, Volatile/metabolism , Fermentation , Flax/chemistry , Humans , Lignans/analysis , Lignans/pharmacokinetics , Male , Models, Animal , Models, Biological , Predictive Value of Tests , Rats , Rats, Wistar , Secale/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...